U.S. survey links kratom use with cannabis and heroin use, with sex differences
Kratom Use Among U.S. Adults: Clinical Characteristics and Sex Differences in Co-Occurring Drug Use.
AI Summary
This study used 2022–2023 U.S. National Survey on Drug Use and Health data to estimate lifetime kratom use among adults and examine its demographic, mental-health, behavioral, and substance-use correlates. The estimated lifetime prevalence was 1.95%; among adults reporting lifetime use, 34.84% also reported past-year use and 18.39% past-month use. These are survey associations, not evidence that kratom caused the characteristics observed.
Lifetime kratom use was associated with lifetime major depressive episodes, use of pain-relieving medications, and past-year serious psychological distress. Lifetime cannabis and heroin use were associated with higher odds of kratom use in both sexes, but the cannabis association was stronger in males and the heroin association weaker in males than in females. Because this is an observational analysis of self-reported survey data, it cannot establish causation or show whether screening or intervention would help; this is an abstract-based summary, not a review of the full text.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
Treatment records show a sharp rise in stimulant use in Oman, 2019–2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risks…
Barcelona survey links teen pornography use with cannabis use and other outcomes
Explore More Research
Stay informed about the latest cannabis science.